Skip to Content

BMS 250MG 6673 (Videx EC 250 mg)

Generic Name: didanosine

Pill imprint BMS 250MG 6673 has been identified as Videx EC 250 mg.

Videx EC is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). There is no proven risk in humans during pregnancy. Videx EC 250 mg is not a controlled substance under the Controlled Substance Act (CSA).

Videx EC 250 mg BMS 250MG 6673
Videx EC 250 mg BMS 250MG 6673
Discount Card Promo
Videx EC
Generic Name:
didanosine
Imprint:
BMS 250MG 6673
Strength:
250 mg
Color:
White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Bristol-Myers Squibb
National Drug Code (NDC):
00087-6673
Inactive Ingredients:
carboxymethylcellulose sodium
diethyl phthalate
methacrylic acid - methyl methacrylate copolymer (1:2)
sodium hydroxide
sodium starch glycolate type A potato
magnesium silicate
gelatin
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-5504 A-S Medication Solutions, LLC (repackager)
54868-5595 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide